AGF-18440-42818
2 vaccinations
20 coded responses
22 check-ins
20 free-text entries
7 call cases
- Sex
- Female
- Age at first dose
- 46-50
- ZIP prefix
- 750 / TX
- Registered
- 2021-03-09
- Relationship
- Self
- Race
- Multiracial
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2021-03-09
Registered in v-safe
-
2021-03-09
Dose 1 — Pfizer-BioNTech
-
2021-03-09
Survey response — day 0, dose 1MedDRA: Rash erythematous, Vertigo — Feeling: Fair · Site: Pain, Swelling · Fever · Headache, Muscle or body aches, Fatigue or tiredness · Be unable to do your normal daily activitiesFree text: Vertigo, skin feels like sunburnMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-03-10
Survey response — days 1–6 daily, dose 1MedDRA: Aphasia, Skin burning sensation, Vertigo — Feeling: Poor · Site: Pain, Swelling · Fever · Chills, Headache, Joint pains, Muscle or body aches, Fatigue or tiredness, Nausea, Rash, not including the immediate area around the injection site · Be unable to do your normal daily activitiesFree text: vertigo, skin burning, aphasia worseMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-03-11
Survey response — days 1–6 daily, dose 1MedDRA: Pharyngeal swelling, Skin burning sensation, Swelling face, Vertigo — Feeling: Fair · Fever · Chills, Headache, Joint pains, Muscle or body aches, Fatigue or tiredness, Nausea, Rash, not including the immediate area around the injection site · Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Telehealth, virtual health, or email health consultationFree text: skin burning, vertigo, throat swelling, face puffyMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-03-11
Report sent to call center — days 1–6 daily, dose 1Be unable to do your normal daily activities · Get care from a doctor or other healthcare professional1 call case(s)
-
2021-03-12
Survey response — days 1–6 daily, dose 1MedDRA: Pharyngeal swelling — Feeling: Fair · Headache, Joint pains, Muscle or body aches, Fatigue or tiredness · Be unable to do your normal daily activitiesFree text: throat swellingMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-03-13
Survey response — days 1–6 daily, dose 1MedDRA: Pharyngeal swelling — Feeling: Fair · Muscle or body aches, Fatigue or tiredness · Be unable to do your normal daily activitiesFree text: throat swellingMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-03-14
Survey response — days 1–6 daily, dose 1MedDRA: Pharyngeal swelling — Feeling: Fair · Joint pains, Muscle or body aches, Fatigue or tiredness · Be unable to do your normal daily activitiesFree text: throat swellingMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-03-15
Survey response — days 1–6 daily, dose 1MedDRA: Pharyngeal swelling — Feeling: Fair · Headache, Muscle or body aches, Fatigue or tiredness · Be unable to do your normal daily activitiesFree text: throat swellingMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-03-16
Survey response — day 7, dose 1MedDRA: Pharyngeal swelling — Feeling: Fair · Headache, Joint pains, Muscle or body aches, Fatigue or tiredness · Be unable to do your normal daily activitiesFree text: Throat swellingMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
- 2021-03-23
-
2021-03-30
Dose 2 — Pfizer-BioNTech
-
2021-03-31
Survey response — days 1–6 daily, dose 2MedDRA: Pharyngeal swelling, Vertigo — Feeling: Fair · Site: Pain, Swelling · Headache, Joint pains, Muscle or body aches, Fatigue or tiredness · Be unable to do your normal daily activitiesFree text: vertigo, throat swellingMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-04-01
Survey response — days 1–6 daily, dose 2MedDRA: Dyspnoea exertional, Lymphadenopathy, Pharyngeal swelling, Vertigo — Feeling: Poor · Site: Pain, Swelling · Chills, Headache, Joint pains, Muscle or body aches, Fatigue or tiredness, Nausea, Abdominal pain · Be unable to do your normal daily activitiesFree text: lymph nodes swelling behind ears, throat swelling, vertigo, out of breath with mild activityMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-04-02
Health check-in — days 1–6 daily, dose 2Feeling: Poor · Site: Swelling, Itching · Chills, Headache, Joint pains, Muscle or body aches, Fatigue or tiredness · Be unable to do your normal daily activitiesAdult check-in
-
2021-04-03
Survey response — days 1–6 daily, dose 2MedDRA: Dyspnoea, Oropharyngeal pain, Upper-airway cough syndrome — Feeling: Poor · Chills, Headache, Joint pains, Muscle or body aches, Fatigue or tiredness · Be unable to do your normal daily activitiesFree text: breathing difficulty with mild activity, post-nasal drip, sore throatMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-04-04
Survey response — days 1–6 daily, dose 2MedDRA: Dyspnoea, Dyspnoea exertional — Feeling: Fair · Headache, Joint pains, Muscle or body aches, Fatigue or tiredness · Be unable to do your normal daily activitiesFree text: shortness of breath with mild activityMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-04-06
Survey response — day 7, dose 2MedDRA: Pharyngeal swelling, Vertigo — Feeling: Poor · Fever · Headache, Joint pains, Muscle or body aches, Fatigue or tiredness, Nausea · Be unable to do your normal daily activitiesFree text: throat swelling, vertigoMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-04-13
Survey response — day 14, dose 2MedDRA: Abdominal pain, Dyspnoea, Muscle spasms, Night sweats — Feeling: Poor · Be unable to do your normal daily activitiesFree text: Trouble breathing, abdominal pain, night sweats, muscle spasms and crampingMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-04-20
Survey response — day 21, dose 2MedDRA: Arthralgia, Eczema, Fatigue, Headache, Specialist consultation, Vertigo — Feeling: Poor · Be unable to work, Be unable to do your normal daily activities, Get care from a doctor or other healthcare professionalFree text: Symptoms: Eczema, extreme fatigue, joint pain, headaches, vertigo · Healthcare visit (other): primary care providerMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-04-20
Report sent to call center — day 21, dose 2Be unable to work · Be unable to do your normal daily activities · Get care from a doctor or other healthcare professional1 call case(s)
-
2021-04-27
Survey response — day 28, dose 2MedDRA: Dyspnoea, Eczema, Fatigue, Headache — Feeling: Poor · Be unable to work, Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Telehealth, virtual health, or email health consultationFree text: Breathing problems, headaches, joint pain, memory loss, extreme fatigue, menstrual changes, eczema worseMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-04-27
Report sent to call center — day 28, dose 2Be unable to work · Be unable to do your normal daily activities · Get care from a doctor or other healthcare professional1 call case(s)
-
2021-05-04
Survey response — day 35, dose 2MedDRA: Amnesia, Dyspnoea, Eczema, Goitre, Headache, Menstrual disorder, Swelling, Tremor, Vertigo — Feeling: Poor · Be unable to work or attend school, Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Telehealth, virtual health, or email health consultationFree text: Memory loss, thyroid swelling, neck swelling, eczema, no menstrual cycle since first shot,headaches, vertigo, hand and body tremors, breathing problemsMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-05-04
Report sent to call center — day 35, dose 2Be unable to work · Be unable to do your normal daily activities · Get care from a doctor or other healthcare professional1 call case(s)
-
2021-06-29
Survey response — 3 months, dose 2MedDRA: Chest pain, Dyspnoea, Tremor — Feeling: Poor · Be unable to work or attend school, Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Telehealth, virtual health, or email health consultation, Outpatient clinic or urgent care clinic visitFree text: Chest pain, trouble breathing on any exertion, tremors, previous symptoms still presentMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-06-29
Report sent to call center — 3 months, dose 2Be unable to work or attend school · Be unable to do your normal daily activities · Get care from a doctor or other healthcare pr1 call case(s)
- 2021-07-01
- 2021-07-02
-
2021-07-02
Call successfulCompleted over the phone
-
2021-09-30
Survey response — 6 months, dose 2MedDRA: Eczema, Pre-existing disease — Feeling: Fair · Get care from a doctor or other healthcare professional · Telehealth, virtual health, or email health consultationFree text: Severe eczema, and food allergies that require an epipenMedDRA releases: 2024-11 · check-in free text available
-
2021-09-30
Report sent to call center — 6 months, dose 2Get care from a doctor or other healthcare professionalTelehealth, virtual health, or email health consultation · 1 call case(s)
-
2021-11-15
Call successfulReported to VAERS voluntarily prior to GDIT contact
-
2022-04-01
Survey response — 12 months, dose 2MedDRA: Amnesia, Confusional state, Disorientation, Headache, Migraine — Feeling: Poor · Be unable to work or attend school, Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Telehealth, virtual health, or email health consultationFree text: Increased memory loss, confusion, disorientation. Severe headaches, Increased migraines.MedDRA releases: 2024-11 · check-in free text available
-
2022-04-01
Report sent to call center — 12 months, dose 2Be unable to work or attend school · Be unable to do your normal daily activities · Get care from a doctor or other healthcare prTelehealth, virtual health, or email health consultation · 1 call case(s)
-
2022-04-05
Call successfulReported to VAERS during previous contact from GDIT
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-03-09 | Pfizer-BioNTech | |
| 2 | 2021-03-30 | Pfizer-BioNTech |
Call center
7 call center cases
7 successful
VAERS report filed, before or during a call: 7
Free text
Release 5 — day 0, dose 1
Systemic reaction (other): Vertigo, skin feels like sunburn
Release 5 — days 1–6 daily, dose 1
Systemic reaction (other): vertigo, skin burning, aphasia worse
Systemic reaction (other): skin burning, vertigo, throat swelling, face puffy
Systemic reaction (other): throat swelling
Systemic reaction (other): throat swelling
Systemic reaction (other): throat swelling
Systemic reaction (other): throat swelling
Release 5 — day 7, dose 1
Systemic reaction (other): Throat swelling
Release 6 — days 1–6 daily, dose 2
Systemic reaction (other): vertigo, throat swelling
Systemic reaction (other): lymph nodes swelling behind ears, throat swelling, vertigo, out of breath with mild activity
Systemic reaction (other): breathing difficulty with mild activity, post-nasal drip, sore throat
Systemic reaction (other): shortness of breath with mild activity
Release 7 — day 7, dose 2
Systemic reaction (other): throat swelling, vertigo
Release 7 — day 14, dose 2
Symptoms: Trouble breathing, abdominal pain, night sweats, muscle spasms and cramping
Release 7 — day 21, dose 2
Symptoms: Eczema, extreme fatigue, joint pain, headaches, vertigo
Healthcare visit (other): primary care provider
Release 8 — day 28, dose 2
Symptoms: Breathing problems, headaches, joint pain, memory loss, extreme fatigue, menstrual changes, eczema worse
Release 8 — day 35, dose 2
Symptoms: Memory loss, thyroid swelling, neck swelling, eczema, no menstrual cycle since first shot,headaches, vertigo, hand and body tremors, breathing problems
Release 9 — 3 months, dose 2
Symptoms: Chest pain, trouble breathing on any exertion, tremors, previous symptoms still present
Release 9 — 6 months, dose 2
Symptoms: Severe eczema, and food allergies that require an epipen
Release 11 — 12 months, dose 2
Symptoms: Increased memory loss, confusion, disorientation. Severe headaches, Increased migraines.
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| HCVO | Specialist consultation | ✓ | ✓ | ✓ |
| SD | Abdominal pain | ✓ | ✓ | ✓ |
| SD | Amnesia | ✓ | ✓ | ✓ |
| SD | Arthralgia | ✓ | ✓ | ✓ |
| SD | Chest pain | ✓ | ✓ | ✓ |
| SD | Confusional state | · | · | ✓ |
| SD | Disorientation | · | · | ✓ |
| SD | Dyspnoea | ✓ | ✓ | ✓ |
| SD | Eczema | ✓ | ✓ | ✓ |
| SD | Fatigue | ✓ | ✓ | ✓ |
| SD | Goitre | ✓ | ✓ | ✓ |
| SD | Headache | ✓ | ✓ | ✓ |
| SD | Menstrual disorder | ✓ | ✓ | ✓ |
| SD | Migraine | · | · | ✓ |
| SD | Muscle spasms | ✓ | ✓ | ✓ |
| SD | Night sweats | ✓ | ✓ | ✓ |
| SD | Pre-existing disease | · | · | ✓ |
| SD | Swelling | ✓ | ✓ | ✓ |
| SD | Tremor | ✓ | ✓ | ✓ |
| SD | Vertigo | ✓ | ✓ | ✓ |
| SRO | Aphasia | ✓ | ✓ | ✓ |
| SRO | Dyspnoea | ✓ | ✓ | ✓ |
| SRO | Dyspnoea exertional | ✓ | ✓ | ✓ |
| SRO | Lymphadenopathy | ✓ | ✓ | ✓ |
| SRO | Oropharyngeal pain | ✓ | ✓ | ✓ |
| SRO | Pharyngeal swelling | ✓ | ✓ | ✓ |
| SRO | Rash erythematous | ✓ | ✓ | ✓ |
| SRO | Skin burning sensation | ✓ | ✓ | ✓ |
| SRO | Swelling face | ✓ | ✓ | ✓ |
| SRO | Upper-airway cough syndrome | ✓ | ✓ | ✓ |
| SRO | Vertigo | ✓ | ✓ | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release